The 17th Annual Sickle Cell Disease Research and Educational Symposium and 46th National Sickle Cell Disease Scientific Meeting

“Is Wall Street Still Interested in Sickle Cell Disease?”

Ted W. Love, MD

Former CEO
Global Blood Therapeutics
San Francisco, California, United States

Gerard Smith, MD

Deep Track Capital
Greenwich, Connecticut, United States

Jim Birchenough, MD

Vice Chairman
Wells Fargo Biopharmaceutical Investment Banking
Tiburon , California, United States